"Cell Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.
| Descriptor ID |
D002470
|
| MeSH Number(s) |
G04.346
|
| Concept/Terms |
Cell Survival- Cell Survival
- Survival, Cell
- Cell Viability
- Cell Viabilities
- Viabilities, Cell
- Viability, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Survival".
Below are MeSH descriptors whose meaning is more specific than "Cell Survival".
This graph shows the total number of publications written about "Cell Survival" by people in this website by year, and whether "Cell Survival" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 2 | 3 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 4 | 4 |
| 2003 | 2 | 5 | 7 |
| 2004 | 0 | 13 | 13 |
| 2005 | 0 | 9 | 9 |
| 2006 | 1 | 4 | 5 |
| 2007 | 1 | 7 | 8 |
| 2008 | 1 | 11 | 12 |
| 2009 | 1 | 13 | 14 |
| 2010 | 0 | 17 | 17 |
| 2011 | 4 | 15 | 19 |
| 2012 | 0 | 14 | 14 |
| 2013 | 0 | 26 | 26 |
| 2014 | 0 | 26 | 26 |
| 2015 | 0 | 19 | 19 |
| 2016 | 2 | 14 | 16 |
| 2017 | 1 | 16 | 17 |
| 2018 | 1 | 10 | 11 |
| 2019 | 0 | 15 | 15 |
| 2020 | 0 | 14 | 14 |
| 2021 | 0 | 7 | 7 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Survival" by people in Profiles.
-
deepOrganoid: A brightfield cell viability model for screening matrix-embedded organoids. SLAS Discov. 2022 04; 27(3):175-184.
-
Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells. Mol Pharmacol. 2022 01; 101(1):1-12.
-
Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. ACS Appl Mater Interfaces. 2021 Oct 27; 13(42):49614-49630.
-
Mechanism of Anti-Inflammatory Activity of TLR4-Interacting SPA4 Peptide. Immunohorizons. 2021 08 24; 5(8):659-674.
-
Polymer-coated microparticle scaffolds engineered for potential use in musculoskeletal tissue regeneration. Biomed Mater. 2021 05 24; 16(4).
-
VEGF Mediates Retinal Müller Cell Viability and Neuroprotection through BDNF in Diabetes. Biomolecules. 2021 05 10; 11(5).
-
Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression. Microb Cell Fact. 2021 Mar 10; 20(1):67.
-
Development and Characterization of PLGA-Based Multistage Delivery System for Enhanced Payload Delivery to Targeted Vascular Endothelium. Macromol Biosci. 2021 03; 21(3):e2000377.
-
Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers. Bioorg Chem. 2021 02; 107:104595.
-
Nimbolide induces cell death in T lymphoma cells: Implication of altered apoptosis and glucose metabolism. Environ Toxicol. 2021 Apr; 36(4):628-641.